Patents Assigned to Vivex Biologics Group, Inc.
  • Patent number: 11925532
    Abstract: A vented wound dressing barrier includes one or more membrane layers with a plurality of vents. The vents are cut along a perimeter of the vents through the one or more membrane layers. Each vent having a connection portion uncut relative to the one or more membrane layers thereby forming a hinge configured to allow the vents to open for drainage when exposed to fluid underlying the vented wound dressing barrier. The plurality of vents is each cut along the perimeter without removal of any of the membrane layer. The one or more membrane layers with the plurality of vents has a surface for covering a wound, the surface area in the absence of a fluid pressing on the vents having no openings or voids which reduce the surface area of a vented wound dressing barrier area covering a wound.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: March 12, 2024
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Timothy Ganey, Shabnam Namin, Hanna Kaliada, Santiago Osorio
  • Patent number: 11918704
    Abstract: A method of making infused non-demineralized cartilage fibers employs the following steps: cutting or shaving cartilage tissue into cartilage long aspect ratio fibers, washing the fibers, and infusing the fibers with a supernatant of biologic material or a polyampholyte cryoprotectant or a combination of both to create infused fibers.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: March 5, 2024
    Assignee: Vivex Biologics Group, Inc.
    Inventor: Timothy Ganey
  • Patent number: 11471559
    Abstract: A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: October 18, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Timothy Ganey, Wendy W. Weston, Miguel Quevedo, Stuart Oglesby, Tracy Scott Anderson
  • Patent number: 11452744
    Abstract: A transplant product made from human amniotic fluid has a supernatant from filtered and centrifuged amniotic fluid, the amniotic fluid when recovered aseptically having a clear, translucent to slightly pink or tan color. The supernatant had been taken from the amniotic fluid which had been passed through a 170 to 260 micron blood filter, then centrifuged for 5 minutes or more at 400 g and thereafter the supernatant was separated from a pellet of debris, leaving the biochemical properties intact, wherein the supernatant is cryofrozen in sized cryovials having 0.25 to 2.0 ml of the supernatant at a temperature of ?65 degrees or less prior to use and the transplant products method of use. The transplant product contains cellular material, cell fragments, proteins and growth factors maintaining the biochemical properties and is non-immunogenic while having particles up to 170 microns being passable through a 30 gauge syringe for injection.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: September 27, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Shabnam Namin, Gaëtan Jean-Robert Delcroix
  • Patent number: 11419961
    Abstract: An osteogenic composition suitable for use in bone and soft tissue reparative procedures is provided for herein. Methods for preparing osteogenic composition from blood and bone marrow are also provided for. The osteogenic compositions contain therapeutically effective concentrations of one or more osteogenic agents such as BMP-2, TGF-?, PDGF and VEGF.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: August 23, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventor: Hugo Pedrozo
  • Patent number: 11406734
    Abstract: A malleable demineralized bone composition consists of cortical bone made from a first portion and a second portion. The first portion and second portion of cortical bone is made from cut pieces freeze dried then ground into particles and demineralized then freeze-dried. A volume of the second portion is placed in a solution of sterile water to create a mixture, the water volume being seven times the volume of the second portion, the mixture is autoclaved under heat and pressure to form a gelatin, and the first portion is mixed with the gelatin to form a malleable putty or paste.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: August 9, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Silvia Daniela Gonzales, Shabnam Namin, Timothy Ganey
  • Patent number: 11344855
    Abstract: A mixing container with an internal mixing blade has an extraction funnel, a main housing, a rotatable base cap, a mixing blade and a gear mechanism. The extraction funnel has a first end with a maximum diameter and narrowing to a second end of a minimum diameter at a neck portion. The main housing includes a mixing chamber. The rotatable base cap with an internal gear is attached to and is rotatable relative to the main housing. The mixing blade has a plurality of prongs extending from a shaft. The prongs are in the mixing chamber and the shaft extends through an opening in the main housing to inside the rotatable base cap. The gear mechanism has at least one gear, each of the at least one gears is connected to or intermeshed with the internal gear of the base cap and the gear of the shaft end.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: May 31, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Vanessa Baron, Shabnam Namin
  • Patent number: 11253630
    Abstract: A malleable demineralized bone composition consists of cortical bone made from a first portion and a second portion. The first portion and second portion of cortical bone is made from cut pieces freeze dried then ground into particles and demineralized then freeze-dried. A volume of the second portion is placed in a solution of sterile water to create a mixture, the water volume being seven times the volume of the second portion, the mixture is autoclaved under heat and pressure to form a gelatin, and the first portion is mixed with the gelatin to form a malleable putty or paste.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: February 22, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Silvia Daniela Gonzales, Shabnam Namin, Timothy Ganey
  • Patent number: 11253629
    Abstract: A bone gel composition consists of cortical bone. The cortical bone is made from cut pieces freeze-dried then ground into particles and demineralized then freeze-dried. A volume of the particles is placed in a solution of sterile water to create a mixture, the water volume being at least twice the particle volume, the mixture is autoclaved under heat and pressure to form a gelatin, the resulting bone gel is formed into sheets having a thickness (t).
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: February 22, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Wendy W. Weston, Silvia Daniela Gonzales, Edgar S. Maldonado
  • Patent number: 11229468
    Abstract: A syringe mixing device has a cylindrical syringe housing, an end cap, a nozzle cap, a removable stir rod mixer assembly, a large mouth funnel, and optional locking clip. The cylindrical syringe housing has an internal chamber for holding material, a distal end and a proximal end. Adjacent the proximal end is a pair of finger grips. The end cap has a proximal end for attaching to the distal end of the syringe housing. The end cap has a nozzle configured to pass material ejected from the syringe housing. The nozzle cap is for sealing the nozzle. The large mouth funnel is configured to fasten at a throat end to the distal end of the cylindrical syringe housing. The funnel has a slope shaped chamber configured to receive and pass material for mixing into the internal chamber of the syringe housing. The syringe mixing device further has a removable plunger.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: January 25, 2022
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Silvia Daniela Gonzales, Shabnam Namin, William Blake Martin, Timothy Ganey
  • Patent number: 11077148
    Abstract: A biological composition has a mixture of mechanically selected allogeneic biologic material derived from placental tissue. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.
    Type: Grant
    Filed: April 11, 2018
    Date of Patent: August 3, 2021
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Timothy Ganey, Wendy W. Weston, Gaëtan Jean-Robert Delcroix
  • Patent number: 11077147
    Abstract: A biological composition has a mixture of mechanically selected allogeneic biologic material derived from placental tissue. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: August 3, 2021
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Timothy Ganey, Wendy W. Weston, Gaëtan Jean-Robert Delcroix
  • Patent number: 10842825
    Abstract: A transplant product made from human amniotic fluid has a supernatant from filtered and centrifuged amniotic fluid, the amniotic fluid when recovered aseptically having a clear, translucent to slightly pink or tan color. The supernatant had been taken from the amniotic fluid which had been passed through a 170 to 260 micron blood filter, then centrifuged for 5 minutes or more at 400 g and thereafter the supernatant was separated from a pellet of debris, leaving the biochemical properties intact, wherein the supernatant is cryofrozen in sized cryovials having 0.25 to 2.0 ml of the supernatant at a temperature of ?65 degrees or less prior to use and the transplant products method of use. The transplant product contains cellular material, cell fragments, proteins and growth factors maintaining the biochemical properties and is non-immunogenic while having particles up to 170 microns being passable through a 30 gauge syringe for injection.
    Type: Grant
    Filed: July 5, 2019
    Date of Patent: November 24, 2020
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Shabnam Namin, Gaëtan Jean-Robert Delcroix
  • Patent number: 10829740
    Abstract: A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture is compatible with biologic function.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: November 10, 2020
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Timothy Ganey, Wendy W. Weston, Miguel Quevedo, Stuart Oglesby, Gaetan Jean-Robert Delcroix, Paul C. Schiller, Gianluca D'Ippolito
  • Patent number: 10760058
    Abstract: A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: September 1, 2020
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Timothy Ganey, Wendy W. Weston, Miguel Quevedo, Stuart Oglesby, Gaetan Jean-Robert Delcroix, Paul C. Schiller, Gianluca D'Ippolito
  • Patent number: 10743994
    Abstract: The present invention relates to a fenestrated bone graft and a method of preparing cortical bone in thin strips then fully demineralizing it to give it formed flexibility and then creating fenestrations in the cortical bone in a fashion similar to but not identical to skin grafts.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: August 18, 2020
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Harry Thomas Temple, Tracy Scott Anderson, Edgar S. Maldonado, Sonya A. Cooper
  • Patent number: 10682440
    Abstract: The present invention relates to a fenestrated bone wrap graft and a method of preparing cortical bone in thin sheets then fully demineralizing it to give it formed flexibility and then creating fenestrations in the cortical bone in a fashion similar to, but not identical to, skin grafts.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: June 16, 2020
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Tracy Scott Anderson, John Johnson
  • Patent number: 10645921
    Abstract: A viable disc regenerative composition has a micronized material of nucleus pulposus and a biological composition made from a mixture of mechanically selected allogeneic biologic material derived from bone marrow having non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components; and wherein the mixture is compatible with biologic function and further includes non-expanded whole cells. The biological composition is predisposed to demonstrate or support elaboration of active volume or spatial geometry consistent in morphology with that of disc tissue. The viable disc regenerative composition extends regenerative resonance that compliments or mimics disc tissue complexity.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: May 12, 2020
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Harry Thomas Temple, Timothy Ganey, Stephanie Gonzalez, Tracy Scott Anderson, Shabnam Namin
  • Patent number: 10596298
    Abstract: A malleable demineralized bone composition consists of cortical bone made from a first portion and a second portion. The first portion of cortical bone is made from cut pieces freeze dried then ground into particles and demineralized then freeze-dried. The second portion of cortical bone is shaved into shavings. The shavings are long thin strips subjected to freeze-drying. The freeze-dried shavings are ground and demineralized and then freeze-dried. A volume of the second portion is placed in a solution of sterile water to create a mixture, the water volume being twice the second portion, the mixture is autoclaved under heat and pressure to form a gelatin, and the first portion is mixed with the gelatin to form a malleable putty or paste.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: March 24, 2020
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Edgar S. Maldonado, Silvia Daniela Gonzales
  • Patent number: D911547
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: February 23, 2021
    Assignee: Vivex Biologics Group, Inc.
    Inventors: Vanessa Baron, Shabnam Namin